Global Autoimmune Disease Diagnostics Market USD 14.8 Billion by 2020, Market Study by iHealthcareAnalyst, Inc.
Maryland Heights, MO, November 29, 2016 --(PR.com)-- The global autoimmune disease diagnostics market was valued at USD 12.4 Billion in 2015 and is estimated to reach USD 14.8 Billion by 2020, at a CAGR of 3.6% from 2016 to 2020 - iHealthcareAnalyst, Inc.
Browse the Autoimmune Disease Diagnostics Market Analysis and Forecast 2016-2020 at https://www.ihealthcareanalyst.com/report/autoimmune-disease-diagnostics-market/
An autoimmune disease occurs when the body’s immune system begins to attack its own antigens. Autoimmune disease diagnostic tests can be defined as laboratory tests that are performed to diagnose autoimmune disorders. These tests include blood tests for one or more autoantibodies and tests for inflammation. Autoimmune disease laboratory testing involves complete blood count with differential, comprehensive metabolic panel, inflammatory markers, antinuclear antibodies, autoantibodies, CRP, ESR, urinalysis, and flow cytometry. The autoimmune disease diagnostics market is growing at a significant pace due to rise in the number of autoimmune patients, growing health care expenditure, and increase in demand for advanced diagnostic tests.
The global autoimmune disease diagnostics market report estimates the market size (Revenue USD million – 2013 to 2020) for market segmentation based on testing methods and their applications (Grave’s disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Type 1 diabetes, etc.) and forecasts growth trends (CAGR% – 2016 to 2020).
The global autoimmune disease diagnostics market segmentation is based on geography (regional and country based). The global autoimmune disease diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global autoimmune disease diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global autoimmune disease diagnostics market and included in this report are Abbott Laboratories, and Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., and Siemens Healthcare.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Browse the Autoimmune Disease Diagnostics Market Analysis and Forecast 2016-2020 at https://www.ihealthcareanalyst.com/report/autoimmune-disease-diagnostics-market/
An autoimmune disease occurs when the body’s immune system begins to attack its own antigens. Autoimmune disease diagnostic tests can be defined as laboratory tests that are performed to diagnose autoimmune disorders. These tests include blood tests for one or more autoantibodies and tests for inflammation. Autoimmune disease laboratory testing involves complete blood count with differential, comprehensive metabolic panel, inflammatory markers, antinuclear antibodies, autoantibodies, CRP, ESR, urinalysis, and flow cytometry. The autoimmune disease diagnostics market is growing at a significant pace due to rise in the number of autoimmune patients, growing health care expenditure, and increase in demand for advanced diagnostic tests.
The global autoimmune disease diagnostics market report estimates the market size (Revenue USD million – 2013 to 2020) for market segmentation based on testing methods and their applications (Grave’s disease, Hashimoto’s thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus, Type 1 diabetes, etc.) and forecasts growth trends (CAGR% – 2016 to 2020).
The global autoimmune disease diagnostics market segmentation is based on geography (regional and country based). The global autoimmune disease diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global autoimmune disease diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global autoimmune disease diagnostics market and included in this report are Abbott Laboratories, and Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., and Siemens Healthcare.
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories